American CryoStem Corporation is a clinical-stage biotechnology company and a global licensor that specializes in autologous cellular processing and therapies. With their patented CryoStem Platform, they offer a comprehensive cellular therapy solution for treating injuries, disorders, and chronic diseases using adipose tissue fat harvest and cryopreservation. Their mission is to improve clinical outcomes and enhance patient health and quality of life by developing and delivering cutting-edge stem cell therapies.
As a pioneer in the fields of Regenerative and Personalized Medicine, American CryoStem Corporation is dedicated to advancing research, development, and application of stem cell technology. They focus on clinical processing, commercial bio-banking, and application development for adipose fat tissue and autologous adipose-derived regenerative cells (ADRCs). With their state-of-the-art stem cell technology, they provide personalized regenerative medicine programs that utilize a patient's own stem cells to restore their appearance and address various medical conditions.
Generated from the website